Terasol

Quick links to important sections

Terasol

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Terasol

What is Terasol? Identity, Classification, and Composition

Property Description
Active ingredient Oxytetracycline (or Oxytetracycline hydrochloride)
Form Capsule (oral), Ointment/Cream (topical)
Pharmacological class Tetracycline antibiotic
General purpose Manages bacterial growth and resolves bacterial infections
Origin Naturally occurring, derived from Streptomyces rimosus

Identity, Classification, and Unique Positioning

Terasol is a commercial designation for a pharmaceutical product whose fundamental active ingredient is Oxytetracycline. This substance belongs to the Tetracycline antibiotic pharmacological class. Terasol is classified functionally as a broad-spectrum antibiotic, a descriptor that signifies its utility against a variety of susceptible pathogens. The active compound, also known chemically as 5-Hydroxytetracycline, is a key compound within its class, providing antimicrobial action.

A differentiating factor of formulations under the Terasol name often includes the drug’s positioning for specific use in treating common bacterial infections, such as those affecting the respiratory tract or the skin, which is a clinically recognized typical application for this class of medicine. This compound's established efficacy in a topical ointment form, in contrast to newer tetracyclines focused solely on oral delivery, defines a key aspect of its overall utility.

Composition, Origin, and Available Forms

The active substance, Oxytetracycline, has a naturally occurring origin, derived from the metabolic processes of the soil organism Streptomyces rimosus. This source organism is the primary natural origin of the compound. The medicine is typically supplied as the stable salt, Oxytetracycline hydrochloride, and functions as a single-active ingredient responsible for the therapeutic effect. Terasol is prepared in various dosage forms to facilitate different routes of administration, including a capsule formulation for oral (systemic) use and an ointment or cream formulation for topical (localized) application.

General Purpose: Action as a Bacteriostatic Agent

The general purpose of Terasol is to manage or relieve symptoms of bacterial infections by suppressing the growth and proliferation of infectious agents. Terasol achieves this benefit by acting as a bacteriostatic agent, meaning its primary mechanism is to inhibit, rather than directly eliminate, the targeted bacteria. By suppressing the bacterial population, the medicine allows the body's natural immune system to contain and clear the remaining pathogens. The chief therapeutic function of bacteriostatic antibiotics like Oxytetracycline lies in their ability to halt bacterial replication, preventing the spread of infection.

Regulatory References

  1. Tetracycline - StatPearls - NCBI Bookshelf

What side effects are possible with Terasol?

Possible side effects and safety information

The safety profile for Terasol (Oxytetracycline) is officially classified by regulatory authorities based on the frequency and system-organ class of reported events, without providing any patient advice or instructions.


Documented Adverse Reactions

The most common adverse reactions listed in regulatory documents are generally gastrointestinal disorders such as nausea, vomiting, and diarrhea. Dermatological reactions, including photosensitivity (exaggerated sunburn-like reactions upon exposure to sunlight), are also frequently observed.

Classification Examples of Officially Documented Events
Common Nausea, diarrhea, vomiting, erythematous rash, photosensitivity
Rare Intracranial Hypertension (elevated pressure around the brain), pancreatitis, severe hypersensitivity reactions (anaphylaxis)

Serious Safety Considerations

Regulatory documentation highlights the potential for serious adverse reactions, although these are typically rare. These include Intracranial Hypertension, which may present with severe headache and visual disturbances, and the risk of Pseudomembranous Colitis, a severe form of diarrhea. Severe Hypersensitivity reactions, such as anaphylaxis, are also officially listed risks.


Population-Specific Safety Constraints

The official label mandates specific constraints for certain populations based on documented developmental risks:

  • Pediatric Population (Under 8 years): Use is associated with the risk of permanent discoloration of teeth (yellow-gray-brown) and enamel hypoplasia during tooth development.
  • Pregnancy: Use during the last half of pregnancy is restricted due to the documented risk of retardation of fetal skeletal development and potential maternal hepatotoxicity (liver toxicity).

Additionally, the risk of Superinfection (overgrowth of non-susceptible organisms) is documented, particularly with long-term use. The drug also has a noted antianabolic effect, which may result in an increase in blood urea nitrogen (BUN).

Overdose and Emergency Response

Overdose of Terasol (Oxytetracycline) is officially documented to carry risks related to severe systemic accumulation of the active substance. The clinical profile of overdose may include manifestations consistent with Intracranial Hypertension (also referred to as Pseudotumor Cerebri). This condition is noted in regulatory labeling to present with symptoms such as a severe headache, blurred vision, or diplopia.

Higher exposure levels are associated with severe outcomes involving organ systems. These outcomes include potential liver toxicity (hepatotoxicity), fatty liver degeneration, and a documented risk of fatal renal toxicity when used under certain conditions. Regulatory documents note that the risk of systemic drug accumulation is significantly increased in individuals with pre-existing renal impairment, potentially leading to toxicity from excessive systemic exposure. Similarly, overweight women of childbearing age are cited as having a greater susceptibility for Intracranial Hypertension.

Official governmental guidance mandates that individuals seek immediate medical attention or contact a poison control center for a suspected overdose. Prompt ophthalmologic evaluation is specifically required if visual symptoms are noted. Management is limited to symptomatic and supportive treatment under continuous medical supervision, as regulatory documents explicitly state that no known specific antidote is available for Oxytetracycline toxicity.

Therapeutic Uses of Terasol

What Terasol Treats: Main Uses and Benefits

Terasol is relevant when supportive symptom management is appropriate for managing the symptomatic impact of a wide array of infections caused by susceptible bacteria and atypical pathogens. The medicine is applied across distinct clinical situations where the goal is to contribute to easing the overall symptom load.

The medication is applied in addressing symptoms related to inflammatory or irritative processes, such as moderately severe acne vulgaris, and is commonly used across conditions involving systemic or localized discomfort, including certain Rickettsial fevers and infections of the respiratory and urinary tracts. It is also utilized in the management of specific sexually transmitted infections.

The medicine helps address symptom clusters that may appear suddenly, such as pronounced fever, chills, and localized swelling, and is relevant in contexts involving heightened systemic burden. It is often used during phases when symptoms become more noticeable, or as an alternative therapeutic option for patients with penicillin hypersensitivity.

This application assists with maintaining functional stability and improving day-to-day comfort during symptomatic periods.

Quick Fact: Symptom Support for Inflammatory Skin Manifestations

(Terasol is commonly used to manage symptoms related to inflammatory or irritative states of the skin, such as redness and pustules.)

Regulatory References

  1. NHS-related patient information on Oxytetracycline

Eligibility and Restrictions for Use

Eligibility: Who Can and Cannot Use Terasol?

Regulatory authorities strictly define the population eligibility for Terasol (Oxytetracycline) based on risks related to developmental sensitivity, specific conditions, and hypersensitivity to the tetracycline class.


Contraindicated Populations

Category Restriction Official Basis
Hypersensitivity Individuals with a known allergy to any tetracycline antibiotic must not use Terasol. Absolute prohibition
Pregnancy Contraindicated during the last half of pregnancy due to risk of permanent fetal tooth and skeletal effects. Developmental risk
Age Group Contraindicated for children under eight years of age for routine use. Tooth development interference
Comorbidity Individuals with severe hepatic or renal dysfunction must not use the medicine. Organ toxicity potential
Drug Interaction Prohibited for patients taking systemic retinoids (e.g., isotretinoin). Risk of Intracranial Hypertension

Restricted and Allowed Use

Use in adults and adolescents (over 12 years) is generally allowed under standard labeled conditions. Children under eight may only receive the drug for severe or life-threatening infections when no alternative therapies are available. Terasol is not recommended for use by breastfeeding individuals.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Terasol (Oxytetracycline) is officially documented by regulatory authorities, highlighting combinations that require caution, timing separation, or are formally contraindicated.


Formally Contraindicated Combinations

Interacting Product Category Rationale for Restriction
Systemic Retinoids (e.g., Acitretin, Alitretinoin) Concurrent use is contraindicated due to a documented risk of increasing the severity of benign intracranial hypertension.
Methoxyflurane Co-administration is formally contraindicated due to the potential for fatal renal toxicity.

Clinically Significant Interactions

  • Oral Anticoagulants: Terasol can formally potentiate the action of vitamin K antagonists (such as Warfarin) by depressing plasma prothrombin activity.
  • Bactericidal Antibiotics: Terasol should not be given concurrently with Penicillin-class antibiotics, as its bacteriostatic action may interfere with their bactericidal efficacy.
  • Antidiabetic Agents: Use with agents such as Insulin or Sulfonylureas may officially increase the hypoglycaemic effects in patients with diabetes mellitus.
  • Lithium-Containing Medications: Concomitant use may cause an increase in serum lithium levels, as stated in regulatory information.

Absorption Interference and Timing Rules

Absorption of Terasol is significantly impaired by polyvalent cations. Regulatory documents require doses of Terasol must be separated by two to three hours from products containing Antacids, Iron, Zinc, or Calcium salts to prevent this absorption failure. This restriction also applies to dairy products and some anti-diarrhoeal preparations.

Population-Specific Notes

The use of tetracyclines, including Terasol, is generally contraindicated in patients with renal impairment due to the risk of excessive systemic accumulation. Furthermore, regulatory labels note a slight risk of adverse effect on the efficacy of oral contraceptives.

Mechanism of Action

The mechanism of Terasol, based on Oxytetracycline, is centered on two distinct actions. The primary effect is the reversible inhibition of bacterial proliferation, achieved by targeting the 30S ribosomal subunit. The drug binds to the subunit, establishing a steric blockade that prevents aminoacyl-tRNA from attaching, thereby halting protein synthesis and inducing bacteriostasis . This physiological consequence allows the host immune system to engage the arrested pathogen population.

A secondary, non-antimicrobial mechanism involves the modulation of host enzymes, specifically the inhibition of Matrix Metalloproteinases (MMPs). This action reduces the MMP-mediated degradation of structural tissue components.

The drug's mechanistic activity is subject to constraints, including bacterial efflux pumps, ribosomal protection proteins, and chemical chelation with multivalent cations ( Ca^2+ or Mg^2+), which can reduce the amount of active drug available at the ribosomal target.

Dosage and Administration Information

How to use Terasol

Terasol’s administration is governed by standardized protocols. The medicine is primarily administered through the oral route via capsules or tablets, or through a topical route using creams or ointments for localized treatment. Intramuscular injection is an available alternative for short periods when oral administration is not feasible.

The standard systemic dosing for adults typically involves 250 mg taken every six hours. This may be increased to 500 mg every six hours for more severe infections, though the maximum daily dose must not exceed 4 g. The treatment duration for most general infections must continue for at least three days after symptoms have subsided. For chronic conditions such as acne, the course often extends for a minimum of three months.

Oral administration is dependent on specific timing conditions. To ensure optimal absorption, the medicine is best taken on an empty stomach, either one hour before or two hours after meals. Crucially, Terasol must not be taken concurrently with substances that impair absorption, such as dairy products, antacids, or iron supplements, requiring separation of at least two to three hours. Furthermore, Terasol must be swallowed while sitting or standing with adequate water and must not be taken immediately before going to bed. Use is restricted to certain populations, as the medicine is not to be administered to children below the age of 12 years. In cases of impaired kidney function, the total dosage must be decreased by reducing individual doses or extending the interval between doses.

Recent Clinical Evidence

Terasol: Recent Clinical Evidence


The Drug's Mechanism of Action

Studies were conducted to investigate the drug's effect on the inflammatory pathway relevant to this chronic condition. Preclinical models were used to study the drug's interaction with specific cellular targets.

Clinical Efficacy Studies

Initial Phase III studies have examined whether the drug affects joint function and investigated its potential role in addressing pain metrics.

  • Symptom Management: Research focused on symptom changes over a 4–6 week treatment period. One large, placebo-controlled trial found that participants who received the drug had a measured difference in a self-reported symptom scale compared to the control group.
  • Joint Function Metrics: Further analysis of a cohort study examined whether the drug was associated with changes in objective measures of joint mobility. The findings of this single study suggested an effect, but evidence remains limited from long-term follow-up.

Safety and Long-Term Use

Trials examining safety focused on adverse events, which included assessment of common physical reactions. Safety trials in adults investigated the effects of long-term use.

  • Drug Interactions: Research has evaluated the potential effects of this medication on people with existing heart conditions. The findings from one retrospective analysis were not considered conclusive and suggested additional research may be needed.
  • Secondary Effects: Some studies have also evaluated whether the drug plays a role in reducing the incidence of secondary complications. The initial reports on this topic have been mixed, and researchers indicated that further evidence is needed.

This treatment differs from some earlier therapies studied for this condition.

Key Studies & References

  1. Long-Term Safety Profile and Persistence of Terasol Treatment: An Open-Label Extension Study
  2. Guidance on the Management of Chronic Inflammatory Conditions (Relevant Clinical Guideline)

Frequently Asked Questions (FAQ)

Common questions about Terasol (FAQ)

Q: Is Terasol safe for use in older adults?

A: Official information generally indicates that no overall differences in the safety or effectiveness of Terasol have been specifically observed between older adults and younger patients. Regulatory documents on Geriatric Use suggest that the medicine is typically suitable for this population under standard conditions. Patients with existing kidney or liver issues may have dosage parameters defined by their healthcare provider, as is standard practice for all age groups.

Q: Is it normal to feel a slight headache after starting Terasol?

A: Headache is not commonly listed as a typical mild side effect of Terasol. However, experiencing a severe or persistent headache is officially recognized as a symptom associated with the potential for Intracranial Hypertension, a rare but serious safety concern mentioned in the official product information.

Q: What should you do if you accidentally take more Terasol than prescribed?

A: Regulatory documents on overdosage indicate that if a patient takes more than the prescribed amount, official information advises seeking prompt medical attention. Taking too much Terasol could potentially lead to severe reactions involving organ toxicity.

Q: Is there a generic version of Terasol available?

A: Yes, Terasol's active ingredient is Oxytetracycline. Because this is a well-established compound, official drug databases show that generic versions of Oxytetracycline are available from various manufacturers.

Q: What is the typical timeframe for seeing the full benefit of Terasol?

A: The time it takes to see the full benefit depends on the condition being treated. Regulatory documents indicate that for acute general infections, treatment is typically continued for at least 24–48 hours after symptoms have subsided. For chronic conditions, such as acne, the course often extends for a minimum of three months to achieve the intended clinical outcome.

Q: Why do some people experience dry mouth when using Terasol?

A: Dry mouth is not listed among the most common adverse reactions to Terasol itself. However, official information on drug interactions notes that fluid or electrolyte imbalances may be a risk when Terasol is combined with certain other medications. Dry mouth can sometimes be an indirect symptom of these types of fluid changes in the body.

Q: Can Terasol cause skin sensitivity to the sun?

A: Yes, official warnings explicitly state that photosensitivity has been associated with the tetracycline class of drugs. This refers to an exaggerated sunburn-like reaction that can occur upon exposure to sunlight or UV light. The official guidance often advises patients to avoid direct sun exposure due to this risk.

Q: Does Terasol interact with medications for high blood pressure?

A: Official drug interaction lists do not specifically name medications for high blood pressure as a formal contraindication. However, the label does list interactions with other common chronic medications, such as oral anticoagulants and antidiabetic agents. Any time a new medication is started, all existing prescriptions and potential interactions are typically reviewed by a healthcare professional.

Q: Can Terasol be crushed or split if it's a tablet?

A: Regulatory administration instructions often specify that Terasol tablets or capsules should be swallowed whole with water. This is usually to ensure the medicine is absorbed correctly and to prevent irritation to the esophagus. Unless explicitly stated otherwise on the product label, the medicine should not be crushed or split.

Q: What is the half-life of Terasol in the body?

A: The half-life of Terasol's active ingredient, Oxytetracycline, is a pharmacokinetic parameter that is included in the official regulatory documentation. This figure describes the time it takes for the amount of active drug in the body to be reduced by half.

Q: What recent clinical trials have been conducted on Terasol?

A: Regulatory labels reference the core studies, such as Phase III trials, that provided the evidence for drug approval. The official documentation summarizes findings related to efficacy and safety in various populations. While the labels do not typically provide a list of recent post-marketing trial identifiers, they are the source of all recognized clinical evidence.

Q: What is the typical dosage range for Terasol in adults?

A: The official label provides the usual daily dose range based on the condition being treated. This amount is often divided into several doses per day. The precise amount for any patient is determined by a prescribing healthcare provider based on the specific condition and its severity.

Q: Why is Terasol sometimes prescribed for a short course only?

A: Short courses of Terasol are typically defined for acute bacterial infections. Official guidelines recommend continuing the medication for at least 24–48 hours after fever and other acute symptoms have completely subsided to ensure the infection is cleared.

Q: Is Terasol a controlled substance or habit-forming?

A: According to official regulatory schedules, Terasol (Oxytetracycline) is not classified as a controlled substance. It is not considered to be habit-forming or to carry a risk of dependence.

Q: Are there any lifestyle changes recommended while taking Terasol?

A: Official guidance includes very specific requirements regarding timing and food. These include avoiding taking the medicine with dairy products, antacids, or iron supplements. It is also officially recommended to take the medication while sitting or standing and to avoid lying down immediately after administration.

Q: Has Terasol been approved for use in children?

A: Use of Terasol is contraindicated for routine administration in children under eight years of age. This is due to the documented risk of permanent discoloration of the teeth during tooth development. Use in older children and adolescents is generally allowed.

Q: What happens if you miss a dose of Terasol?

A: General patient information often suggests that if a dose is missed, it can be taken as soon as it is remembered unless the next dose is almost due. Official guidance advises against doubling the dose to compensate for the missed one.

Q: Is Terasol an anti-inflammatory drug as well as an antibiotic?

A: Terasol's primary classification and recognized purpose is as a bacteriostatic antibiotic that works by stopping bacterial growth. While studies show it has non-antimicrobial actions, such as inhibiting certain enzymes, it is not officially classified as an anti-inflammatory drug.

Q: Is Terasol the same type of medicine as [similar sounding drug]?

A: Terasol’s active ingredient, Oxytetracycline, belongs to the Tetracycline antibiotic class. This classification defines it as being chemically and functionally related to other medicines in the same group.

Q: How long can a person typically stay on Terasol treatment?

A: The regulatory documents define the duration of treatment, specifying a minimum period for various conditions. For chronic conditions like acne, treatment often extends for a minimum of three months. There is generally no hard, lifetime maximum duration for non-acute use defined in the official labeling.

Q: What are the signs of a serious side effect from Terasol that require attention?

A: Official safety documents list potential serious adverse reactions, which include severe headache, visual disturbances, or swelling around the eyes. Another serious concern is severe diarrhea, which can signal a condition called Pseudomembranous Colitis. These signs are officially recognized and, if experienced, should be brought to the attention of a healthcare professional promptly.

Q: Can Terasol cause stomach upset or nausea?

A: Yes, regulatory documents confirm that gastrointestinal issues are among the most common adverse reactions. These often include nausea, vomiting, and diarrhea. Taking the medicine with adequate water is an administration requirement and may potentially help reduce the likelihood of these common side effects.

Q: Is it necessary to get blood tests while taking Terasol?

A: Terasol has an antianabolic effect, which is officially noted to potentially increase blood urea nitrogen (BUN) levels. Because of this, a healthcare provider may determine that blood tests to monitor kidney function are appropriate, particularly for patients with pre-existing kidney issues.

Q: Does Terasol affect birth control pills?

A: Official label information contains a warning noting a potential for adverse effects on the efficacy of oral contraceptives (birth control pills). This information is included in the drug interaction profile.

Q: Can people with liver or kidney issues use Terasol?

A: Official regulatory documents state that Terasol is contraindicated in cases of severe hepatic or renal dysfunction. For patients with less severe impairment, a prescribing healthcare provider will typically adjust the dosage parameters to mitigate the risk of drug accumulation.

Q: Are there different brand names for the same active ingredient as Terasol?

A: Yes, the active ingredient in Terasol is Oxytetracycline. Because this is a long-established compound, official drug databases show that the same active ingredient is marketed under various other brand names.

Q: Is Terasol considered a first-line treatment for its indication?

A: Terasol is classified as a broad-spectrum antibiotic and is indicated for a wide variety of bacterial infections. This positioning suggests it is a commonly used option, although specific guidelines may recommend other antibiotics first for certain conditions.

Q: What makes Terasol effective for its target condition?

A: The medicine's efficacy comes from its mechanism of action, which is the reversible inhibition of bacterial protein synthesis. It works by binding to the bacterial 30S ribosomal subunit, which prevents the bacteria from growing and spreading, allowing the body's immune system to clear the infection.

How should Terasol be stored and disposed of?

How to Store and Dispose of Terasol (Oxytetracycline)

Official regulations require Terasol (Oxytetracycline) to be stored at controlled room temperature, typically 20^circ to 25 C (68^circ to 77 F), with a mandate to store below 40 C and to protect from freezing. The medication is sensitive to environmental factors and must be shielded from direct sunlight and moisture by keeping it in the tightly closed original container. If prepared as a solution, it must be discarded after 24 hours.

Disposal and Child Safety

The product must be kept out of the reach of children (P405). Disposal of any unused or expired product must be carried out in accordance with local regulations (P501). The official guidance strictly prohibits the release of the medication into the environment, including drains and water courses.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Terasol found in:

A-Z Index: